COMMUNIQUÉS West-GlobeNewswire

Availability of the 2023 Universal Registration Document, including the Annual Financial Report

05/04/2024 - 18:21

Press Release Paris – April 5, 2024 – EUROAPI announces the publication of its 2023 Universal Registration Document, filed with the French Autorité des marchés financiers (AMF) on April 5, 2024. The 2023 Universal [...]

Mise à disposition du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel

05/04/2024 - 18:21

Communiqué de presse Paris – Le 5 avril 2024 – EUROAPI annonce la publication de son Document d’Enregistrement Universel 2023, déposé auprès de l’Autorité des marchés financiers (AMF) le 5 avril 2024. Le Document d’ [...]

PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)

05/04/2024 - 18:00

Lyon (France) and Cambridge (MA, US), 5 April 2024 – 6:00pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial [...]

PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023

05/04/2024 - 18:00

Lyon (France) et Cambridge (MA, US), le 5 avril 2024 – 18h00 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société biopharmaceutique qui développe des traitements innovants contre les infections [...]

Activation of PA Licensure Compact to Improve Access to Patient Care

05/04/2024 - 17:23

PA compact will eliminate unnecessary barriers to PA practice across state lines ALEXANDRIA, Va., April 05, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA), Federation of State Medical [...]

Theratechnologies Appoints Elina Tea to its Board of Directors

05/04/2024 - 17:00

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]

Theratechnologies nomme Elina Tea à son conseil d’administration

05/04/2024 - 17:00

MONTRÉAL, 05 avr. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point et la commercialisation de [...]

Hapbee Received Commitments for $2.785 Million From Qualified Investors

05/04/2024 - 16:12

VANCOUVER, British Columbia, April 05, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company has announced on [...]

Medicovestor Selected as Finalist to Present Its First-in-Class ADC Platforms at JP Morgan Asset Management: Life Sciences Innovation Summit

05/04/2024 - 16:00

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Medicovestor, Inc. has been chosen as one of 11 finalists from a competitive pool of over 150 applicants spanning more than 20 countries to showcase its innovative Antibody- [...]

HiberCell Announces Recent Publication and Poster Presentations for its Novel GCN2 Activator, HC-7366

05/04/2024 - 16:00

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the publication of “ [...]

New Board Candidate for the upcoming Annual Geneal Meeting

05/04/2024 - 15:46

April 5, 2024 Announcement no. 7 New Board Candidate for the upcoming Annual Geneal Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 5, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an [...]

Safety Shot Closes $5 Million No Warrant Private Placement Priced At-the-Market

05/04/2024 - 15:30

JUPITER, FL, April 05, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (The “Company” or “Safety Shot”) is pleased to announce a private placement (the “Offering”) of $5 million from a private institutional [...]

NGM Bio Announces Closing of Tender Offer

05/04/2024 - 15:19

SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (“NGM Bio”) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today [...]

Praxis Precision Medicines to Participate in Upcoming April Conferences

05/04/2024 - 15:00

BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

05/04/2024 - 15:00

FORT WORTH, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused [...]

IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

05/04/2024 - 15:00

Marks major milestone prior to launch in U.S. market PressureSafe ™ s canner and disposable pack both listed with FDA PressureSafe ™ can support early detection of pressure injuries, potentially setting a new standard [...]

Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia

05/04/2024 - 14:58

Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities TORONTO, April 05, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a [...]

IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer

05/04/2024 - 14:30

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today [...]

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

05/04/2024 - 14:04

Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2026 NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage [...]